Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 485

    1.

    Anti-L-selectin antibody therapy does not worsen the postseptic course in a baboon model.

    Redl HR, Martin U, Khadem A, Pelinka LE, van Griensven M.

    Crit Care. 2005;9(6):R735-44. Epub 2005 Nov 8.PMID: 16356222 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy.

    Welty-Wolf KE, Carraway MS, Ghio A, Kantrow SP, Huang YC, Piantadosi CA.

    Shock. 2000 May;13(5):404-9.PMID: 10807017 [PubMed - indexed for MEDLINE]Related articles

    3.

    Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons.

    Schlag G, Redl HR, Till GO, Davies J, Martin U, Dumont L.

    Crit Care Med. 1999 Sep;27(9):1900-7.PMID: 10507616 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antibody to E- and L-selectin does not prevent lung injury or mortality in septic baboons.

    Carraway MS, Welty-Wolf KE, Kantrow SP, Huang YC, Simonson SG, Que LG, Kishimoto TK, Piantadosi CA.

    Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):938-49.PMID: 9517615 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.

    Stack AM, Saladino RA, Thompson C, Sattler F, Weiner DL, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR.

    Crit Care Med. 1995 Sep;23(9):1512-8.PMID: 7664553 [PubMed - indexed for MEDLINE]Related articles

    7.

    Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model.

    Haley M, Parent C, Cui X, Kalil A, Fitz Y, Correa-Araujo R, Natanson C, Danner RL, Banks SM, Eichacker PQ.

    J Appl Physiol. 2005 Jun;98(6):2155-62. Epub 2005 Jan 27.PMID: 15677732 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia.

    Opal SM, Palardy JE, Parejo N, Jasman RL.

    Crit Care Med. 2003 Mar;31(3):929-32.PMID: 12627007 [PubMed - indexed for MEDLINE]Related articles

    9.

    Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation.

    Bengtsson A, Redl H, Schlag G, Högåsen K, Götze O, Mollnes TE.

    Scand J Immunol. 1998 Nov;48(5):509-14.PMID: 9822260 [PubMed - indexed for MEDLINE]Related articles

    10.

    Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.

    Zisman DA, Kunkel SL, Strieter RM, Gauldie J, Tsai WC, Bramson J, Wilkowski JM, Bucknell KA, Standiford TJ.

    Shock. 1997 Nov;8(5):349-56.PMID: 9361345 [PubMed - indexed for MEDLINE]Related articles

    11.

    Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats.

    Karzai W, Cui X, Mehlhorn B, Straube E, Hartung T, Gerstenberger E, Banks SM, Natanson C, Reinhart K, Eichacker PQ.

    Anesthesiology. 2003 Jul;99(1):81-9.PMID: 12826846 [PubMed - indexed for MEDLINE]Related articles

    12.

    Anti-TNF antibody treatment has no positive effect on survival in a model of pneumococcal sepsis in pigs.

    Gawad KA, Schneider C, Brinken B, Hufländer A, Diederichs B, Mack D, Gutensohn K, Izbicki JR.

    J Invest Surg. 2001 Sep-Oct;14(5):291-7.PMID: 11700923 [PubMed - indexed for MEDLINE]Related articles

    13.

    Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons.

    Welty-Wolf KE, Carraway MS, Miller DL, Ortel TL, Ezban M, Ghio AJ, Idell S, Piantadosi CA.

    Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1988-96.PMID: 11734456 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

    Reinhart K, Wiegand-Löhnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J.

    Crit Care Med. 1996 May;24(5):733-42. Erratum in: Crit Care Med 1996 Sep;24(9):1608. PMID: 8706447 [PubMed - indexed for MEDLINE]Related articles

    15.

    Peritonitis in the baboon: a primate model which stimulates human sepsis.

    Kinasewitz GT, Chang AC, Peer GT, Hinshaw LB, Taylor FB Jr.

    Shock. 2000 Feb;13(2):100-9.PMID: 10670839 [PubMed - indexed for MEDLINE]Related articles

    16.

    Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.

    Remick DG, Call DR, Ebong SJ, Newcomb DE, Nybom P, Nemzek JA, Bolgos GE.

    Crit Care Med. 2001 Mar;29(3):473-81.PMID: 11373406 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of antibiotic induced bacterial clearance in the udder on L-selectin shedding of blood neutrophils in cows with Escherichia coli mastitis.

    Monfardini E, Burvenich C, Massart-Leën AM, Smits E, Paape MJ.

    Vet Immunol Immunopathol. 1999 Mar 1;67(4):373-84.PMID: 10206204 [PubMed - indexed for MEDLINE]Related articles

    18.

    Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin.

    Redl H, Schlag G, Tögel E, Assicot M, Bohuon C.

    Crit Care Med. 2000 Nov;28(11):3659-63.PMID: 11098970 [PubMed - indexed for MEDLINE]Related articles

    19.

    Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular IgM antibody in murine Escherichia coli sepsis.

    Hustinx W, Benaissa-Trouw B, Van Kessel K, Kuenen J, Tavares L, Kraaijeveld K, Verhoef J, Hoepelman A.

    Eur J Clin Invest. 1997 Dec;27(12):1044-8.PMID: 9466134 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide.

    Giamarellos-Bourboulis EJ, Poulaki H, Kostomitsopoulos N, Dontas I, Perrea D, Karayannacos PE, Giamarellou H.

    Antimicrob Agents Chemother. 2003 Aug;47(8):2445-9.PMID: 12878503 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data